Molecular basis for differences between human joints.
The molecular program of a cell determines responses including induction or inhibition of genes for function and activity, and this is true of the cells within articular cartilage, a major functional component of the joint. While our studies have previously focussed on differences in the molecular programs of the cells within the superficial and deep zones, we have recently begun to focus on relative differences between joints, such as the knee and ankle. In the human, these joints vary greatly in their susceptibility to joint diseases, such as osteoarthritis (OA). We have predicted that there would be a molecular basis for differences between joints that could lead to differences in susceptibility to OA, if inherent pathways locked into the resident cells induce differences in their response to their environment. We have been able to show that there are differences between the matrix components and water content; these properties correspond to a higher equilibrium modulus and dynamic stiffness but lower hydraulic permeability and serve to make the ankle cartilage stiffer, slowing movement of molecules through the cartilage. In addition to these biochemical differences in the cartilage matrix, we have also identified relative differences in the strength of the response to stimulation of chondrocytes from knee and ankle. The stronger response of the knee chondrocytes includes factors that increase damage to the cartilage matrix, such as a depression of matrix synthesis and increased enzyme activity. This response by the knee chondrocytes results in enzyme damage to the matrix that the cells may not be able to repair, while the weaker response of the ankle chondrocytes may allow the cells to repair their matrix damage.
Cole
A A
AA
Department of Biochemistry, Rush Medical College at Rush-Presbyterian-St. Luke's Medical Center, Chicago, Illinois 60612, USA. acole@rush.edu
Kuettner
K E
KE
D000464:Alginates; D000843:Ankle Joint / Q000187:drug effects / Q000378:metabolism* / Q000473:pathology* / Q000503:physiopathology; D002358:Cartilage, Articular / Q000166:cytology / Q000187:drug effects / Q000378:metabolism / Q000473:pathology*; D004198:Disease Susceptibility; D005109:Extracellular Matrix / Q000378:metabolism; D005353:Fibronectins / Q000378:metabolism; D020723:Glucuronic Acid; D006603:Hexuronic Acids; D006801:Humans; D007375:Interleukin-1 / Q000494:pharmacology; D007719:Knee Joint / Q000187:drug effects / Q000378:metabolism* / Q000473:pathology* / Q000503:physiopathology; D010003:Osteoarthritis / Q000378:metabolism / Q000473:pathology* / Q000503:physiopathology*
D000464:Alginates; D005353:Fibronectins; D006603:Hexuronic Acids; D007375:Interleukin-1; D020723:Glucuronic Acid